Nagano, Japan

Yasuhiro Oda

This inventor holds 3 USPTO granted patents. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2002-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasuhiro Oda. Retrieved from https://idiyas.com/inventor/yasuhiro-oda-52a3c35n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2002-2007

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yasuhiro Oda: Innovator in Thrombocytopenia Treatment

Introduction

Yasuhiro Oda is a notable inventor based in Nagano-ken, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of thrombocytopenia. With a total of 3 patents to his name, Oda's work has the potential to impact many lives.

Latest Patents

Oda's latest patents focus on innovative methods for increasing blood platelet formation. One of his key inventions is an agent for preventing and treating thrombocytopenia, which involves administering a parathyroid hormone (PTH) or at least one PTH derivative as an active ingredient. This method aims to enhance the body's ability to produce platelets, which are crucial for blood clotting.

Career Highlights

Yasuhiro Oda is currently associated with Chugai Pharmaceutical Co., Ltd., where he continues to develop groundbreaking treatments. His dedication to research and innovation has positioned him as a leader in his field.

Collaborations

Oda collaborates with Masahiko Tamura, a fellow researcher, to further advance their work in thrombocytopenia treatment. Their partnership exemplifies the importance of teamwork in scientific research.

Conclusion

Yasuhiro Oda's contributions to the medical field, particularly in thrombocytopenia treatment, highlight his innovative spirit and commitment to improving patient care. His work continues to inspire future advancements in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…